On the public citation graph

Systematic Drug Repositioning for a Wide Range of Diseases with Integrative Analyses of Phenotypic and Molecular Data

0 signed · 146 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamainternmed.2014.3634openalex-snapshot

Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer

inferredcites →https://doi.org/10.1002/ijc.2910320302openalex-snapshot

Sodium butyrate produces concordant expression of “early placental” alkaline phosphatase, pregnancy‐specific beta1‐glycoprotein and human chorionic gonadotropin beta‐subunit in a newly established uterine cervical cancer cell line (SKG‐IIIa)

inferredcites →https://doi.org/10.1007/s13238-012-2011-zopenalex-snapshot

Study of drug function based on similarity of pathway fingerprint

inferredcites →https://doi.org/10.1016/j.artmed.2009.11.002openalex-snapshot

Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods

inferredcites →https://doi.org/10.1016/j.clml.2011.03.001openalex-snapshot

Treatment of Indolent Lymphoma in Germany - Results of a Representative Population-Based Survey

inferredcites →https://doi.org/10.1016/j.exphem.2012.04.003openalex-snapshot

Drug-interaction studies evaluating T-cell proliferation reveal distinct activity of dasatinib and imatinib in combination with cyclosporine A

inferredcites →https://doi.org/10.1016/j.jcv.2012.10.005openalex-snapshot

Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis

inferredcites →https://doi.org/10.1016/j.jinf.2012.12.004openalex-snapshot

Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease

inferredcites →https://doi.org/10.1016/j.leukres.2014.01.010openalex-snapshot

Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib

inferredcites →https://doi.org/10.1016/j.pharmthera.2013.01.016openalex-snapshot

Structure and dynamics of molecular networks: A novel paradigm of drug discovery

inferredcites →https://doi.org/10.1016/j.sbi.2006.01.013openalex-snapshot

Can we rationally design promiscuous drugs?

inferredcites →https://doi.org/10.1016/j.tips.2013.03.004openalex-snapshot

Challenges and opportunities of drug repositioning

inferredcites →https://doi.org/10.1016/s0022-3565(25)10513-2openalex-snapshot

Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.

inferredcites →https://doi.org/10.1016/s0065-7743(06)41024-1openalex-snapshot

Structure–Activity Relationships for In vitro and In vivo Toxicity

inferredcites →https://doi.org/10.1016/s0165-6147(00)01584-4openalex-snapshot

In silico research in drug discovery

inferredcites →https://doi.org/10.1016/s0167-6296(02)00126-1openalex-snapshot

The price of innovation: new estimates of drug development costs

inferredcites →https://doi.org/10.1016/s1359-6446(05)03632-9openalex-snapshot

Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug development

inferredcites →https://doi.org/10.1017/s1047951110000594openalex-snapshot

Acute viral myocarditis: role of immunosuppression: a prospective randomised study

inferredcites →https://doi.org/10.1021/ci9001876openalex-snapshot

PubChem as a Source of Polypharmacology

inferredcites →https://doi.org/10.1038/448645aopenalex-snapshot

New uses for old drugs

inferredcites →https://doi.org/10.1038/clpt.2009.103openalex-snapshot

Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses

inferredcites →https://doi.org/10.1038/clpt.2012.96openalex-snapshot

Pharmacogenomics Knowledge for Personalized Medicine

inferredcites →https://doi.org/10.1038/eye.2008.289openalex-snapshot

Case–control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection

inferredcites →https://doi.org/10.1038/leu.2008.261openalex-snapshot

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

inferredcites →https://doi.org/10.1038/msb.2009.98openalex-snapshot

A side effect resource to capture phenotypic effects of drugs

inferredcites →https://doi.org/10.1038/msb.2011.26openalex-snapshot

PREDICT: a method for inferring novel drug indications with application to personalized medicine

inferredcites →https://doi.org/10.1038/nrd1468openalex-snapshot

Drug repositioning: identifying and developing new uses for existing drugs

inferredcites →https://doi.org/10.1038/sj.bjc.6605555openalex-snapshot

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk

inferredcites →https://doi.org/10.1073/pnas.1000138107openalex-snapshot

Discovery of drug mode of action and drug repositioning from transcriptional responses

inferredcites →https://doi.org/10.1093/bioinformatics/bts057openalex-snapshot

A co-module approach for elucidating drug–disease associations and revealing their molecular basis

inferredcites →https://doi.org/10.1093/bioinformatics/bts412openalex-snapshot

Identification of chemogenomic features from drug–target interaction networks using interpretable classifiers

inferredcites →https://doi.org/10.1093/bioinformatics/bts413openalex-snapshot

Drug target prediction using adverse event report systems: a pharmacogenomic approach

inferredcites →https://doi.org/10.1093/nar/30.1.52openalex-snapshot

Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders

inferredcites →https://doi.org/10.1093/nar/gkl999openalex-snapshot

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

inferredcites →https://doi.org/10.1093/nar/gkm862openalex-snapshot

SuperTarget and Matador: resources for exploring drug-target relationships

inferredcites →https://doi.org/10.1093/nar/gkm882openalex-snapshot

KEGG for linking genomes to life and the environment

inferredcites →https://doi.org/10.1093/nar/gkp896openalex-snapshot

KEGG for representation and analysis of molecular networks involving diseases and drugs

inferredcites →https://doi.org/10.1093/nar/gkq1126openalex-snapshot

DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs

inferredcites →https://doi.org/10.1093/nar/gkr777openalex-snapshot

ChEMBL: a large-scale bioactivity database for drug discovery

inferredcites →https://doi.org/10.1093/nar/gkt1207openalex-snapshot

STITCH 4: integration of protein–chemical interactions with user data

inferredcites →https://doi.org/10.1093/oxfordjournals.annonc.a058801openalex-snapshot

Interferon-α, 5-FU and prednisone in metastatic renal cell carcinoma: A phase II study

inferredcites →https://doi.org/10.1097/00005131-200201000-00003openalex-snapshot

Treatment Outcome of Nonclostridial Gas Gangrene at a Level 1 Trauma Center

inferredcites →https://doi.org/10.1111/j.1365-2141.2009.07919.xopenalex-snapshot

Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia

inferredcites →https://doi.org/10.1111/j.1399-3046.2011.01518.xopenalex-snapshot

Successful rescue of refractory acute antibody‐mediated renal allograft rejection with splenectomy – A case report

inferredcites →https://doi.org/10.1126/science.1132939openalex-snapshot

The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

inferredcites →https://doi.org/10.1126/science.1158140openalex-snapshot

Drug Target Identification Using Side-Effect Similarity

inferredcites →https://doi.org/10.1126/scitranslmed.3001318openalex-snapshot

Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

inferredcites →https://doi.org/10.1126/scitranslmed.3006960openalex-snapshot

Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

inferredcites →https://doi.org/10.1128/aac.48.3.747-752.2004openalex-snapshot

Antibiotic Susceptibility of Tropheryma whipplei in MRC5 Cells

inferredcites →https://doi.org/10.1136/ard.35.6.502openalex-snapshot

Detection by electron microscope of rod-shaped organisms in synovial membrane from a patient with the arthritis of Whipple's disease.

inferredcites →https://doi.org/10.1155/2012/952359openalex-snapshot

Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels

inferredcites →https://doi.org/10.1155/2013/478349openalex-snapshot

Whipple’s Disease: Our Own Experience and Review of the Literature

inferredcites →https://doi.org/10.1159/000364880openalex-snapshot

Pharmacoeconomic Implications of Lenalidomide Maintenance Therapy in Multiple Myeloma

inferredcites →https://doi.org/10.1179/000349804225003037openalex-snapshot

Benzathine penicillin, metronidazole and benzyl penicillin in the treatment of tetanus: a randomized, controlled trial

inferredcites →https://doi.org/10.1182/blood-2011-07-368167openalex-snapshot

Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma

inferredcites →https://doi.org/10.1186/1471-2210-8-5openalex-snapshot

A global view of drug-therapy interactions

inferredcites →https://doi.org/10.1186/1752-0509-7-s6-s18openalex-snapshot

Inferring protein domains associated with drug side effects based on drug-target interaction network

inferredcites →https://doi.org/10.1186/1758-2946-5-30openalex-snapshot

Drug repositioning: a machine-learning approach through data integration

inferredcites →https://doi.org/10.1186/s12941-014-0037-1openalex-snapshot

Evaluation of the anti-Listeria potentials of some plant-derived triterpenes

inferredcites →https://doi.org/10.1200/jco.2009.24.0143openalex-snapshot

Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of…

inferredcites →https://doi.org/10.1371/journal.pone.0006536openalex-snapshot

Human Disease-Drug Network Based on Genomic Expression Profiles

inferredcites →https://doi.org/10.1371/journal.pone.0028025openalex-snapshot

Systematic Drug Repositioning Based on Clinical Side-Effects

inferredcites →https://doi.org/10.1371/journal.pone.0030028openalex-snapshot

Modularity in Protein Complex and Drug Interactions Reveals New Polypharmacological Properties

inferredcites →https://doi.org/10.1371/journal.pone.0078518openalex-snapshot

Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data

inferredcites →https://doi.org/10.1371/journal.pone.0087864openalex-snapshot

Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning

inferredcites →https://doi.org/10.3109/00365548909021703openalex-snapshot

Vibrio vulnificus Infection

inferredcites →https://doi.org/10.3126/kumj.v9i1.6262openalex-snapshot

Clinical Profile of Invasive Pneumococcal Disease in Patan Hospital, Nepal

inferredcites →https://doi.org/10.3816/cbc.2010.n.048openalex-snapshot

A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/ccr3.6980openalex-snapshot

A trial of topiramate for patients with hereditary spinocerebellar ataxia

inferred← citeshttps://doi.org/10.1002/minf.201500109openalex-snapshot

CNS Multiparameter Optimization Approach: Is it in Accordance with Occam’s Razor Principle?

inferred← citeshttps://doi.org/10.1002/minf.202200001openalex-snapshot

Drug Repurposing for Newly Emerged Diseases via Network‐based Inference on a Gene‐disease‐drug Network

inferred← citeshttps://doi.org/10.1002/minf.202300336openalex-snapshot

Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation**

inferred← citeshttps://doi.org/10.1002/psp4.12108openalex-snapshot

Integrating Clinical Phenotype and Gene Expression Data to Prioritize Novel Drug Uses

inferred← citeshttps://doi.org/10.1007/978-981-97-4828-0_9openalex-snapshot

Drug Discovery and Drug Repositioning Using Computational Methods

inferred← citeshttps://doi.org/10.1007/s10822-018-0117-yopenalex-snapshot

DR2DI: a powerful computational tool for predicting novel drug-disease associations

inferred← citeshttps://doi.org/10.1007/s12247-024-09818-wopenalex-snapshot

Repurposing of IL 33/ST2 Modulating Drugs as a Cardioprotective Agent: A Promising Approach

inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12283-8openalex-snapshot

Drug Repurposing Review

inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00014-6openalex-snapshot

Drug Repurposing in Search of Anti-Infectives: Need of the Hour in the Multidrug Resistance Era!

inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00015-8openalex-snapshot

Application of In Silico Drug Repurposing in Infectious Diseases

inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.03.035openalex-snapshot

Drug repurposing for neurodegenerative diseases

inferred← citeshttps://doi.org/10.1016/j.compbiomed.2019.05.006openalex-snapshot

DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy

inferred← citeshttps://doi.org/10.1016/j.drudis.2021.08.002openalex-snapshot

Evaluating the performance of drug-repurposing technologies

inferred← citeshttps://doi.org/10.1016/j.drudis.2021.09.012openalex-snapshot

Combining repurposed drugs to treat colorectal cancer

inferred← citeshttps://doi.org/10.1021/acs.jcim.5b00330openalex-snapshot

Target-Based Drug Repositioning Using Large-Scale Chemical–Protein Interactome Data

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01395openalex-snapshot

4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b01044openalex-snapshot

Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation

inferred← citeshttps://doi.org/10.1038/s41392-022-00994-0openalex-snapshot

Artificial intelligence in cancer target identification and drug discovery

inferred← citeshttps://doi.org/10.1038/s41564-019-0357-1openalex-snapshot

Drug repurposing for antimicrobial discovery

inferred← citeshttps://doi.org/10.1038/s41598-017-15716-8openalex-snapshot

miRDDCR: a miRNA-based method to comprehensively infer drug-disease causal relationships

inferred← citeshttps://doi.org/10.1038/s41598-017-18315-9openalex-snapshot

Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures

inferred← citeshttps://doi.org/10.1039/d3dt02054aopenalex-snapshot

Cage-based sensors for circular dichroism analysis

inferred← citeshttps://doi.org/10.1053/j.gastro.2016.09.065openalex-snapshot

Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases

inferred← citeshttps://doi.org/10.1080/07391102.2023.2199866openalex-snapshot

Vitamin D analog calcitriol for breast cancer therapy; an integrated drug discovery approach

inferred← citeshttps://doi.org/10.1080/1062936x.2016.1209241openalex-snapshot

Scoring multiple features to predict drug disease associations using information fusion and aggregation

inferred← citeshttps://doi.org/10.1080/1062936x.2016.1212922openalex-snapshot

Assessment of the classification abilities of the CNS multi-parametric optimization approach by the method of logistic regression

inferred← citeshttps://doi.org/10.1080/1062936x.2017.1399448openalex-snapshot

How good are publicly available web services that predict bioactivity profiles for drug repurposing?

inferred← citeshttps://doi.org/10.1080/17460441.2017.1295954openalex-snapshot

Exploring the epigenetic drug discovery landscape

inferred← citeshttps://doi.org/10.1093/bib/bby049openalex-snapshot

Disease classification: from phenotypic similarity to integrative genomics and beyond

inferred← citeshttps://doi.org/10.1093/bib/bby061openalex-snapshot

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

inferred← citeshttps://doi.org/10.1093/bib/bbz153openalex-snapshot

Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches

inferred← citeshttps://doi.org/10.1093/bioinformatics/btab191openalex-snapshot

Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug–drug links based on graph neural network

inferred← citeshttps://doi.org/10.1093/bioinformatics/btw770openalex-snapshot

LRSSL: predict and interpret drug–disease associations based on data integration using sparse subspace learning

inferred← citeshttps://doi.org/10.1093/bioinformatics/bty754openalex-snapshot

Understanding and predicting disease relationships through similarity fusion

inferred← citeshttps://doi.org/10.1093/bioinformatics/btz182openalex-snapshot

Drug repositioning through integration of prior knowledge and projections of drugs and diseases

inferred← citeshttps://doi.org/10.1093/database/baac101openalex-snapshot

HCDT: an integrated highly confident drug–target resource

inferred← citeshttps://doi.org/10.1093/jamia/ocw142openalex-snapshot

MeSHDD: Literature-based drug-drug similarity for drug repositioning

inferred← citeshttps://doi.org/10.1098/rsos.190214openalex-snapshot

Disease classification via gene network integrating modules and pathways

inferred← citeshttps://doi.org/10.1109/icde.2019.00209openalex-snapshot

A Prescription Trend Analysis using Medical Insurance Claim Big Data

inferred← citeshttps://doi.org/10.1109/tcbb.2021.3089692openalex-snapshot

Prediction of Drug-Related Diseases Through Integrating Pairwise Attributes and Neighbor Topological Structures

inferred← citeshttps://doi.org/10.1111/bcp.14690openalex-snapshot

Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease

inferred← citeshttps://doi.org/10.1111/jphp.13273openalex-snapshot

Drug repositioning: a brief overview

inferred← citeshttps://doi.org/10.1186/s12859-019-2811-8openalex-snapshot

Drug repositioning of herbal compounds via a machine-learning approach

inferred← citeshttps://doi.org/10.1186/s12859-019-3241-3openalex-snapshot

Biological representation of chemicals using latent target interaction profile

inferred← citeshttps://doi.org/10.1186/s12859-020-03644-wopenalex-snapshot

Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm

inferred← citeshttps://doi.org/10.1186/s12859-020-03800-2openalex-snapshot

LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

inferred← citeshttps://doi.org/10.1186/s13293-022-00420-8openalex-snapshot

Considerations and challenges for sex-aware drug repurposing

inferred← citeshttps://doi.org/10.1186/s40001-023-01048-zopenalex-snapshot

Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis

inferred← citeshttps://doi.org/10.1254/fpj.22072openalex-snapshot

Data-driven drug discovery for drug repurposing

inferred← citeshttps://doi.org/10.1371/journal.pcbi.1005219openalex-snapshot

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction

inferred← citeshttps://doi.org/10.1371/journal.pone.0150460openalex-snapshot

Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures

inferred← citeshttps://doi.org/10.17863/cam.36391openalex-snapshot

Understanding Disease and Disease Relationships Using Transcriptomic Data

inferred← citeshttps://doi.org/10.18097/bmcrm00065openalex-snapshot

Binary classification of blood-brain barrier penetration by the logistic regression method

inferred← citeshttps://doi.org/10.20944/preprints202112.0380.v1openalex-snapshot

Considerations and Challenges for Sex-Aware Drug Repurposing

inferred← citeshttps://doi.org/10.20944/preprints202112.0380.v2openalex-snapshot

Considerations and Challenges for Sex-Aware Drug Repurposing

inferred← citeshttps://doi.org/10.2147/dddt.s405906openalex-snapshot

Knowledge Mapping of Drug Repositioning’s Theme and Development

inferred← citeshttps://doi.org/10.2174/1568026623666230614165548openalex-snapshot

Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment

inferred← citeshttps://doi.org/10.25163/angiotherapy.829423openalex-snapshot

Repurposing Drugs for Overcoming Therapy Resistance in Colon Cancer – A Review

inferred← citeshttps://doi.org/10.3109/1061186x.2015.1132224openalex-snapshot

Physicochemical property profile for brain permeability: comparative study by different approaches

inferred← citeshttps://doi.org/10.3389/fgene.2019.00916openalex-snapshot

An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure

inferred← citeshttps://doi.org/10.3389/fphar.2017.00298openalex-snapshot

On the Integration of In Silico Drug Design Methods for Drug Repurposing

inferred← citeshttps://doi.org/10.3389/fphar.2019.01301openalex-snapshot

HeteroDualNet: A Dual Convolutional Neural Network With Heterogeneous Layers for Drug-Disease Association Prediction via Chou’s Five-Step Rule

inferred← citeshttps://doi.org/10.3390/cancers14184357openalex-snapshot

Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma

inferred← citeshttps://doi.org/10.3390/ijms20174102openalex-snapshot

Prediction of Potential Drug–Disease Associations through Deep Integration of Diversity and Projections of Various Drug Features

inferred← citeshttps://doi.org/10.3390/ijms24010097openalex-snapshot

The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line

inferred← citeshttps://doi.org/10.3390/ph18010014openalex-snapshot

Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures

inferred← citeshttps://doi.org/10.3410/f.727038228.793559539openalex-snapshot

Faculty Opinions recommendation of Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.

inferred← citeshttps://doi.org/10.5772/intechopen.1004703openalex-snapshot

Applications of Molecular Docking Techniques in Repurposing of Drug

inferred← citeshttps://doi.org/10.5772/intechopen.107939openalex-snapshot

COVID-19 Drug Development: Role of Drug Repurposing

inferred← citeshttps://doi.org/10.6084/m9.figshare.13172550openalex-snapshot

Additional file 1 of LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

inferred← citeshttps://doi.org/10.6084/m9.figshare.13172553openalex-snapshot

Additional file 2 of LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

inferred← citeshttps://doi.org/10.6084/m9.figshare.13172556openalex-snapshot

Additional file 3 of LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

inferred← citeshttps://doi.org/10.6084/m9.figshare.13172559openalex-snapshot

Additional file 4 of LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

inferred← citeshttps://doi.org/10.6084/m9.figshare.13172562openalex-snapshot

Additional file 5 of LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

inferred← citeshttps://doi.org/10.6084/m9.figshare.13172565openalex-snapshot

Additional file 6 of LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

inferred← citeshttps://doi.org/10.6084/m9.figshare.13172568openalex-snapshot

Additional file 7 of LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

inferred← citeshttps://doi.org/10.6084/m9.figshare.13172571openalex-snapshot

Additional file 8 of LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.